June 5, 2018 – Gerard Garhöfer, MD, and colleagues reported in a randomized study, that NovaTears has the ability to restore the tear film over time, due to the novel mode of action – perfluorohexyloctane – preventing evaporation by stabilizing the lipid layer.
The following article was published in Primary Care Optometry News on May 22, 2018, and was reported by Nancy Hemphill, ELS, FAAO.